Processing of voided urine for prostate cancer RNA biomarker analysis (Q40308110)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 26 August 2015

Language	Label	Description	Also known as
English	Processing of voided urine for prostate cancer RNA biomarker analysis	scientific article published on 26 August 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Processing of voided urine for prostate cancer RNA biomarker analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

0 references

1 reference

based on heuristic

inferred from title

Ricardo Zorzetto Nicoliello Vêncio

7

object named as

Ricardo Z N Vêncio

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Sue-Ing Quek

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Olivia M Wong

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Adeline Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Gisely T Borges

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

William J Ellis

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Diego M Salvanha

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Brandi Weaver

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yasmin M Ench

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Robin J Leach

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ian M Thompson

11

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Alvin Y Liu

12

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

26 August 2015

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1886-1895

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

A multiplex assay to measure RNA transcripts of prostate cancer in urine

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Prostate cancer biomarker profiles in urinary sediments and exosomes.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Temporal expression profiling of the effects of secreted factors from prostate stromal cells on embryonal carcinoma stem cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Transcriptomes of human prostate cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Bladder expression of CD cell surface antigens and cell-type-specific transcriptomes.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Lineage relationship of prostate cancer cell types based on gene expression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Cell–cell interaction in prostate gene regulation and cytodifferentiation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Differential expression of CD10 in prostate cancer and its clinical implication

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Periostin is up-regulated in high grade and high stage prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Analysis of prostate cancer by proteomics using tissue specimens

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Concordance between transrectal ultrasound guided biopsy results and radical prostatectomy final pathology: Are we getting better at predicting final pathology?

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Exosomes as Biomarker Treasure Chests for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Expressed prostatic secretion biomarkers improve stratification of NCCN active surveillance candidates: performance of secretion capacity and TMPRSS2:ERG models

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Prostasomes: extracellular vesicles from the prostate

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Identifiers

10.1002/PROS.23066

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40308110&oldid=1894237950"